Alkermes’ Corporate Presentation to be Webcast at the UBS Global Healthcare Conference
May 11 2015 - 4:12PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live at the UBS Global Healthcare
Conference on Monday, May 18, 2015, at 2:00 p.m. EDT (7:00 p.m.
BST) from the Sheraton New York Hotel. The presentation may be
accessed under the Investors tab on www.alkermes.com and will be
archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
For AlkermesEva Stroynowski, +1 781 609 6823Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024